Company Overview of Ontogen Corporation
Ontogen Corporation, a drug discovery and development company, focuses on the advancement of small molecule therapeutic agents for the treatment of cancer, infectious diseases, and chronic medical conditions. It engages in the development of ONT-093, a drug for the prevention and reversal of multi-drug resistance associated with cancer chemotherapy, as well as for the oral bioavailability enhancement of chemotherapeutics Taxol and Taxotere. The company also conducts pre-clinical programs that address solid tumor cancer targets, infectious diseases, type-2 diabetes, and wound healing. Ontogen Corporation was founded in 1992 and is headquartered in Carlsbad, California.
2325 Camino Vida Roble
Carlsbad, CA 92009
Founded in 1992
Key Executives for Ontogen Corporation
Similar Private Companies By Industry
|Metronome Therapeutics Inc.||United States|
|Symphony Evolution, Inc.||United States|
|Pilot Therapeutics Holdings Inc.||United States|
|Generics International (US Parent), Inc.||United States|
|National Vitamin Company Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Ontogen Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.